These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 16148263)

  • 1. Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation.
    Aharon-Peretz J; Badarny S; Rosenbaum H; Gershoni-Baruch R
    Neurology; 2005 Nov; 65(9):1460-1. PubMed ID: 16148263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Parkinson's disease and glucocerebrosidase mutations in Brazil.
    Spitz M; Rozenberg R; Pereira Lda V; Reis Barbosa E
    Parkinsonism Relat Disord; 2008; 14(1):58-62. PubMed ID: 17703984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population.
    Toft M; Pielsticker L; Ross OA; Aasly JO; Farrer MJ
    Neurology; 2006 Feb; 66(3):415-7. PubMed ID: 16476943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
    Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher disease: complexity in a "simple" disorder.
    Sidransky E
    Mol Genet Metab; 2004; 83(1-2):6-15. PubMed ID: 15464415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy.
    De Marco EV; Annesi G; Tarantino P; Rocca FE; Provenzano G; Civitelli D; Cirò Candiano IC; Annesi F; Carrideo S; Condino F; Nicoletti G; Messina D; Novellino F; Morelli M; Quattrone A
    Mov Disord; 2008 Feb; 23(3):460-3. PubMed ID: 18074383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the glucocerebrosidase gene in Parkinson's disease.
    Sato C; Morgan A; Lang AE; Salehi-Rad S; Kawarai T; Meng Y; Ray PN; Farrer LA; St George-Hyslop P; Rogaeva E
    Mov Disord; 2005 Mar; 20(3):367-70. PubMed ID: 15517592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Aharon-Peretz J; Rosenbaum H; Gershoni-Baruch R
    N Engl J Med; 2004 Nov; 351(19):1972-7. PubMed ID: 15525722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece.
    Kalinderi K; Bostantjopoulou S; Paisan-Ruiz C; Katsarou Z; Hardy J; Fidani L
    Neurosci Lett; 2009 Mar; 452(2):87-9. PubMed ID: 19383421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela.
    Eblan MJ; Nguyen J; Ziegler SG; Lwin A; Hanson M; Gallardo M; Weiser R; De Lucca M; Singleton A; Sidransky E
    Mov Disord; 2006 Feb; 21(2):282-3. PubMed ID: 16261622
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.
    Alcalay RN; Dinur T; Quinn T; Sakanaka K; Levy O; Waters C; Fahn S; Dorovski T; Chung WK; Pauciulo M; Nichols W; Rana HQ; Balwani M; Bier L; Elstein D; Zimran A
    JAMA Neurol; 2014 Jun; 71(6):752-7. PubMed ID: 24756352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
    Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
    Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers.
    Anheim M; Elbaz A; Lesage S; Durr A; Condroyer C; Viallet F; Pollak P; Bonaïti B; Bonaïti-Pellié C; Brice A;
    Neurology; 2012 Feb; 78(6):417-20. PubMed ID: 22282650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
    Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA
    Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Zimran A; Neudorfer O; Elstein D
    N Engl J Med; 2005 Feb; 352(7):728-31; author reply 728-31. PubMed ID: 15719452
    [No Abstract]   [Full Text] [Related]  

  • 16. Parkinson's disease in patients and obligate carriers of Gaucher disease.
    Becker JG; Pastores GM; Di Rocco A; Ferraris M; Graber JJ; Sathe S
    Parkinsonism Relat Disord; 2013 Jan; 19(1):129-31. PubMed ID: 22940477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of the frequencies of GBA gene major mutations in patients with Gaucher disease in Ukraine].
    Horovenko NH; Ol'khovych NV; Nedoboĭ AM; Pichkur NO
    Tsitol Genet; 2007; 41(4):41-7. PubMed ID: 18030725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal.
    Bras J; Paisan-Ruiz C; Guerreiro R; Ribeiro MH; Morgadinho A; Januario C; Sidransky E; Oliveira C; Singleton A
    Neurobiol Aging; 2009 Sep; 30(9):1515-7. PubMed ID: 18160183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linkage disequilibrium of common Gaucher disease mutations with a polymorphic site in the pyruvate kinase (PKLR) gene.
    Rockah R; Narinsky R; Frydman M; Cohen IJ; Zaizov R; Weizman A; Frisch A
    Am J Med Genet; 1998 Jul; 78(3):233-6. PubMed ID: 9677056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.
    Moraitou M; Hadjigeorgiou G; Monopolis I; Dardiotis E; Bozi M; Vassilatis D; Vilageliu L; Grinberg D; Xiromerisiou G; Stefanis L; Michelakakis H
    Mol Genet Metab; 2011; 104(1-2):149-52. PubMed ID: 21745757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.